Receive the latest updates from Matrix Medical in real time to understand product information.

On September 23, 2023, during the autumnal equinox, Hangzhou Juzheng Medical Technology Co., Ltd. and Sainuo Shenchang Medical Technology Co., Ltd. held a strategic cooperation signing ceremony. The meeting was chaired by Mr. Zhang Guoda, Marketing Director of Juzheng Medical. Guests attending the signing ceremony included Mr. Ji Peihong, Founder of Hangzhou Juzheng Medical Technology Co., Ltd., Mr. Kang Xiaoran, General Manager of Sino Shenchang Medical Technology Co., Ltd., Director Peng Ya, Chief Physician of Neurosurgery at Changzhou First People's Hospital, Professor Liu Yang from the Institute of Biomedical Engineering and Health Sciences at Changzhou University, and Mr. Jin Xiang, CEO of Shukang Group.

(Mr. Ji Peihong, Founder of Hangzhou Juzheng Medical Technology Co., Ltd.)

(Mr. Kang Xiaoran, General Manager of Sainuo Shenchang Medical Technology Co., Ltd.)

The general managers of both companies introduced the development situation of their respective companies, wishing the cooperation between Seno Shenchang and Juzheng Medical to be long-lasting, harmonious, and win-win. The two sides will work together to promote the healthy and sustainable development of innovative medical devices. Mr. Ji Peihong, founder of Juzheng Medical, stated that Juzheng Medical has always adhered to the principle of "intervention without implantation", and its philosophy and practice are parallel. It will continue to combine with the actual needs of the medical industry, innovate continuously in the field of vascular intervention, surpass itself, and develop a series of innovative medical devices for vascular intervention.

Mr. Kang Xiaoran, General Manager of Seno Shenchang, stated that Seno Shenchang relies on Seno Medical Technology Co., Ltd. and has rich and hardcore technical reserves. He hopes that this cooperation with Juzheng Medical can further enrich the company's product line and continue to provide a leading innovation driven neural intervention full product line for clinical use.

Expert Sharing

Director Peng Ya, Chief Neurosurgery Physician of Changzhou First People's Hospital, introduced the challenges of current neurointerventional diagnosis and treatment plans from a clinical perspective, and shared the expert consensus and follow-up solutions for puncture approaches. Provide guidance for the research and development direction of the enterprise.

Professor Liu Yang from the Institute of Biomedical Engineering and Health Sciences at Changzhou University introduced polymer natural biomaterials from the perspective of materials science, shared the relevant scientific research progress in the field of biomedical materials, and provided more ideas on the direction of biomaterials for innovative research and development of medical device products.

Mr. Zhou Qidong, the R&D leader of Hangzhou Matrix Medical Technology Co., Ltd., provided a detailed introduction to the project background and product introduction of the vascular occlusion device

The two sides successfully completed the signing ceremony of strategic cooperation with the motto of 'sailing together in the same boat, sailing through the wind and waves for thousands of miles'. Both parties plan to carry out long-term strategic cooperation on product registration, commercial promotion, and marketing of vascular occlusion devices nationwide.